ArticleJournal of clinical medicine2021
Early Administration of Tolvaptan Can Improve Survival in Patients with Cirrhotic Ascites.
Atsushi Hosui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it